Condition
Homonymous Hemianopsia
Total Trials
4
Recruiting
2
Active
4
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Recruiting2
Active Not Recruiting2
Clinical Trials (4)
Showing 4 of 4 trials
NCT07185971Not ApplicableRecruitingPrimary
PAVE (Parallactic Visual-Field Enhancement) System for Treatment of Chronic Visual Field Loss Due to Stroke, Traumatic Brain Injury, or Brain Surgery
NCT07358832Not ApplicableRecruitingPrimary
Neuromodulation Through Multisensory Stimulation for Visual Field Deficits in the Subacute Stage of Disease
NCT04798924Not ApplicableActive Not Recruiting
Visual Rehabilitation After Occipital Stroke
NCT06674369Active Not RecruitingPrimary
Ongoing Effect of Expansion Prisms Following the Discontinuation of Use on Visual Field Enlargement and Retrograde Ganglion Cell Degeneration in Homonymous Hemianopia Patients
Showing all 4 trials